The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)

Trial Profile

The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 16 Jul 2016

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Fetal growth retardation
  • Focus Therapeutic Use
  • Acronyms STRIDER
  • Most Recent Events

    • 23 Jun 2015 Planned End Date changed from 1 Nov 2018 to 1 Jan 2019 as per ClinicalTrials.gov.
    • 23 Jun 2015 Planned primary completion date changed from 1 Nov 2017 to 1 Jan 2018 as per ClinicalTrials.gov.
    • 27 Oct 2014 Planned End Date changed from 13 Aug 2017 to 1 Nov 2018 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top